Entering text into the input field will update the search result below

Pacira Pharma Q2 revenues up 19%

  • Pacira Pharmaceuticals (NASDAQ:PCRX +5%) Q2 results: Revenues: $84.1M (+18.6%); EXPAREL: $80.4M (+15.2%);  Collaborative licensing and milestone revenue: $3M; Royalty revenue: $0.4M (-42.9%).
  • Net Income: $2.6M; Non-GAAP Net Income: $9.9M; EPS: $0.06; Non-GAAP EPS: $0.24.
  • 2018 Guidance: EXPAREL net product sales: $320M - 325M.

Recommended For You

More Trending News

About PCRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PCRX--
Pacira BioSciences, Inc.